Multitude Therapeutics Inc.
8 clinical trials · Sponsor
◉ Watch Multitude Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| AMT-116 in Combination With AK112 in Patients With Lung Cancer (NCT07590531) | Multitude Therapeutics Inc. | 2026-06-29 |
| AMT-676 in Patients With Advanced Solid Tumors (NCT06400485) | Multitude Therapeutics Inc. | 2024-06-18 |
| AMT-116 in Patients with Solid Tumors (NCT06782334) | Multitude Therapeutics Inc. | 2024-05-07 |
| AMT-253 in Patients With Advanced Solid Tumours (NCT06209580) | Multitude Therapeutics Inc. | 2024-01-31 |
| AMT-116 in Patients With Advanced Solid Tumors (NCT05725291) | Multitude Therapeutics Inc. | 2023-07-25 |
| AMT-151 in Patients With Selected Advanced Solid Tumours (NCT05498597) | Multitude Therapeutics Inc. | 2023-01-25 |
Track Multitude Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.